Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes

Hepatocellular carcinoma (HCC) is the sixth most frequent neoplasm and the second leading cause of cancer‐related deaths worldwide. Nonalcoholic fatty liver disease (NAFLD), a common disorder in obese people, has been identified as an important risk factor for HCC. Following the increasing prevalenc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The FEBS journal 2018-02, Vol.285 (4), p.752-762
Hauptverfasser: Ma, Chi, Zhang, Qianfei, Greten, Tim F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 762
container_issue 4
container_start_page 752
container_title The FEBS journal
container_volume 285
creator Ma, Chi
Zhang, Qianfei
Greten, Tim F.
description Hepatocellular carcinoma (HCC) is the sixth most frequent neoplasm and the second leading cause of cancer‐related deaths worldwide. Nonalcoholic fatty liver disease (NAFLD), a common disorder in obese people, has been identified as an important risk factor for HCC. Following the increasing prevalence of obesity, it is expected that the contribution of NAFLD to HCC's incidence worldwide will grow. Recently, a number of studies have been published, which help us better understand cellular and molecular mechanisms of how NAFLD promotes hepatocarcinogensis. Inflammatory cytokines, ER stress and circadian dysregulation, which mediate hepatocyte injury and NAFLD progression, have been identified to promote malignant transformation of hepatocytes. Besides these ‘intrinsic’ effects, lipid dysregulation dramatically affects the liver local microenvironment. The reshaped immune environment has also been found to contribute to the NAFLD‐mediated hepatocarcinogenesis. This review explores recent findings of both ‘intrinsic’ effects on hepatocytes and the role of the local environment in NAFLD‐promoted HCC development. Nonalcoholic fatty liver disease promotes HCC through both direct effects on hepatocytes, and indirect effects on the environment shaping this into a protumor milieu. NAFLD‐associated events such as the increase of inflammatory cytokines alter gene expression profile of hepatocytes and contribute to malignant transformation. NAFLD also changes the population and functions of liver nonparenchymal cells and favors tumor development.
doi_str_mv 10.1111/febs.14209
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1934280411</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2007922488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3939-4076c86ffde9fe3e739520fb03b98efcc060fce0622cbae3d0f0b01033a0aeed3</originalsourceid><addsrcrecordid>eNp9kU1P3DAQhq0KVL566Q-oLHFBlRbGH0nsY0EsrYTg0CJxsxxn3A1K4q2dgPbf18vucuCAL-ORnnmkmZeQrwzOWX4XHut0ziQH_YkcskrymSwLtff2l48H5CilJwBRSK0_kwOuVFFJVRyS6S4MtnNhEbrWUW_HcUW79hkjbdqENiFdxtCHERNd4NKOwWHXTZ2N1Nno2iH0lo6LGKa_izwR0Y3UDg1th22D3ueSaBh286vsOiH73nYJv2zrMXmYX_-5-jm7vb_5dfXjduaEFnomoSqdKr1vUHsUWAldcPA1iFor9M5BCd4hlJy72qJowEMNDISwYBEbcUzONt68xL8J02j6Nq03sAOGKRmmheQKJGMZPX2HPoUp5tskwwEqzblUKlPfN5SLIaWI3ixj29u4MgzMOgyzDsO8hpHhb1vlVPfYvKG762eAbYCXtsPVByozv778vZH-B3XFl20</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007922488</pqid></control><display><type>article</type><title>Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>Free Full-Text Journals in Chemistry</source><creator>Ma, Chi ; Zhang, Qianfei ; Greten, Tim F.</creator><creatorcontrib>Ma, Chi ; Zhang, Qianfei ; Greten, Tim F.</creatorcontrib><description>Hepatocellular carcinoma (HCC) is the sixth most frequent neoplasm and the second leading cause of cancer‐related deaths worldwide. Nonalcoholic fatty liver disease (NAFLD), a common disorder in obese people, has been identified as an important risk factor for HCC. Following the increasing prevalence of obesity, it is expected that the contribution of NAFLD to HCC's incidence worldwide will grow. Recently, a number of studies have been published, which help us better understand cellular and molecular mechanisms of how NAFLD promotes hepatocarcinogensis. Inflammatory cytokines, ER stress and circadian dysregulation, which mediate hepatocyte injury and NAFLD progression, have been identified to promote malignant transformation of hepatocytes. Besides these ‘intrinsic’ effects, lipid dysregulation dramatically affects the liver local microenvironment. The reshaped immune environment has also been found to contribute to the NAFLD‐mediated hepatocarcinogenesis. This review explores recent findings of both ‘intrinsic’ effects on hepatocytes and the role of the local environment in NAFLD‐promoted HCC development. Nonalcoholic fatty liver disease promotes HCC through both direct effects on hepatocytes, and indirect effects on the environment shaping this into a protumor milieu. NAFLD‐associated events such as the increase of inflammatory cytokines alter gene expression profile of hepatocytes and contribute to malignant transformation. NAFLD also changes the population and functions of liver nonparenchymal cells and favors tumor development.</description><identifier>ISSN: 1742-464X</identifier><identifier>EISSN: 1742-4658</identifier><identifier>DOI: 10.1111/febs.14209</identifier><identifier>PMID: 28857485</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Animals ; Carcinoma, Hepatocellular - immunology ; Carcinoma, Hepatocellular - metabolism ; Carcinoma, Hepatocellular - pathology ; CD4 T cells ; CD8 T cells ; circadian dysregulation ; Circadian rhythms ; Cytokines ; ER stress ; Fatty liver ; gut microbiome ; HCC ; Hepatocellular carcinoma ; Hepatocytes ; Hepatocytes - immunology ; Hepatocytes - metabolism ; Hepatocytes - pathology ; Humans ; Inflammation ; inflammatory cytokine ; Liver ; Liver cancer ; Liver diseases ; Liver Neoplasms - immunology ; Liver Neoplasms - metabolism ; Liver Neoplasms - pathology ; Molecular modelling ; myeloid cells ; NAFLD ; NKT cells ; Non-alcoholic Fatty Liver Disease - immunology ; Non-alcoholic Fatty Liver Disease - metabolism ; Non-alcoholic Fatty Liver Disease - pathology ; Obesity ; Risk Factors ; Tumor Microenvironment - immunology</subject><ispartof>The FEBS journal, 2018-02, Vol.285 (4), p.752-762</ispartof><rights>Published 2017. This article is a U.S. Government work and is in the public domain in the USA.</rights><rights>Copyright © 2018 Federation of European Biochemical Societies</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3939-4076c86ffde9fe3e739520fb03b98efcc060fce0622cbae3d0f0b01033a0aeed3</citedby><cites>FETCH-LOGICAL-c3939-4076c86ffde9fe3e739520fb03b98efcc060fce0622cbae3d0f0b01033a0aeed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Ffebs.14209$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Ffebs.14209$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27903,27904,45553,45554,46388,46812</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28857485$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Chi</creatorcontrib><creatorcontrib>Zhang, Qianfei</creatorcontrib><creatorcontrib>Greten, Tim F.</creatorcontrib><title>Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes</title><title>The FEBS journal</title><addtitle>FEBS J</addtitle><description>Hepatocellular carcinoma (HCC) is the sixth most frequent neoplasm and the second leading cause of cancer‐related deaths worldwide. Nonalcoholic fatty liver disease (NAFLD), a common disorder in obese people, has been identified as an important risk factor for HCC. Following the increasing prevalence of obesity, it is expected that the contribution of NAFLD to HCC's incidence worldwide will grow. Recently, a number of studies have been published, which help us better understand cellular and molecular mechanisms of how NAFLD promotes hepatocarcinogensis. Inflammatory cytokines, ER stress and circadian dysregulation, which mediate hepatocyte injury and NAFLD progression, have been identified to promote malignant transformation of hepatocytes. Besides these ‘intrinsic’ effects, lipid dysregulation dramatically affects the liver local microenvironment. The reshaped immune environment has also been found to contribute to the NAFLD‐mediated hepatocarcinogenesis. This review explores recent findings of both ‘intrinsic’ effects on hepatocytes and the role of the local environment in NAFLD‐promoted HCC development. Nonalcoholic fatty liver disease promotes HCC through both direct effects on hepatocytes, and indirect effects on the environment shaping this into a protumor milieu. NAFLD‐associated events such as the increase of inflammatory cytokines alter gene expression profile of hepatocytes and contribute to malignant transformation. NAFLD also changes the population and functions of liver nonparenchymal cells and favors tumor development.</description><subject>Animals</subject><subject>Carcinoma, Hepatocellular - immunology</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>CD4 T cells</subject><subject>CD8 T cells</subject><subject>circadian dysregulation</subject><subject>Circadian rhythms</subject><subject>Cytokines</subject><subject>ER stress</subject><subject>Fatty liver</subject><subject>gut microbiome</subject><subject>HCC</subject><subject>Hepatocellular carcinoma</subject><subject>Hepatocytes</subject><subject>Hepatocytes - immunology</subject><subject>Hepatocytes - metabolism</subject><subject>Hepatocytes - pathology</subject><subject>Humans</subject><subject>Inflammation</subject><subject>inflammatory cytokine</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Liver diseases</subject><subject>Liver Neoplasms - immunology</subject><subject>Liver Neoplasms - metabolism</subject><subject>Liver Neoplasms - pathology</subject><subject>Molecular modelling</subject><subject>myeloid cells</subject><subject>NAFLD</subject><subject>NKT cells</subject><subject>Non-alcoholic Fatty Liver Disease - immunology</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>Non-alcoholic Fatty Liver Disease - pathology</subject><subject>Obesity</subject><subject>Risk Factors</subject><subject>Tumor Microenvironment - immunology</subject><issn>1742-464X</issn><issn>1742-4658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1P3DAQhq0KVL566Q-oLHFBlRbGH0nsY0EsrYTg0CJxsxxn3A1K4q2dgPbf18vucuCAL-ORnnmkmZeQrwzOWX4XHut0ziQH_YkcskrymSwLtff2l48H5CilJwBRSK0_kwOuVFFJVRyS6S4MtnNhEbrWUW_HcUW79hkjbdqENiFdxtCHERNd4NKOwWHXTZ2N1Nno2iH0lo6LGKa_izwR0Y3UDg1th22D3ueSaBh286vsOiH73nYJv2zrMXmYX_-5-jm7vb_5dfXjduaEFnomoSqdKr1vUHsUWAldcPA1iFor9M5BCd4hlJy72qJowEMNDISwYBEbcUzONt68xL8J02j6Nq03sAOGKRmmheQKJGMZPX2HPoUp5tskwwEqzblUKlPfN5SLIaWI3ixj29u4MgzMOgyzDsO8hpHhb1vlVPfYvKG762eAbYCXtsPVByozv778vZH-B3XFl20</recordid><startdate>201802</startdate><enddate>201802</enddate><creator>Ma, Chi</creator><creator>Zhang, Qianfei</creator><creator>Greten, Tim F.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201802</creationdate><title>Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes</title><author>Ma, Chi ; Zhang, Qianfei ; Greten, Tim F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3939-4076c86ffde9fe3e739520fb03b98efcc060fce0622cbae3d0f0b01033a0aeed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Carcinoma, Hepatocellular - immunology</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>CD4 T cells</topic><topic>CD8 T cells</topic><topic>circadian dysregulation</topic><topic>Circadian rhythms</topic><topic>Cytokines</topic><topic>ER stress</topic><topic>Fatty liver</topic><topic>gut microbiome</topic><topic>HCC</topic><topic>Hepatocellular carcinoma</topic><topic>Hepatocytes</topic><topic>Hepatocytes - immunology</topic><topic>Hepatocytes - metabolism</topic><topic>Hepatocytes - pathology</topic><topic>Humans</topic><topic>Inflammation</topic><topic>inflammatory cytokine</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Liver diseases</topic><topic>Liver Neoplasms - immunology</topic><topic>Liver Neoplasms - metabolism</topic><topic>Liver Neoplasms - pathology</topic><topic>Molecular modelling</topic><topic>myeloid cells</topic><topic>NAFLD</topic><topic>NKT cells</topic><topic>Non-alcoholic Fatty Liver Disease - immunology</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>Non-alcoholic Fatty Liver Disease - pathology</topic><topic>Obesity</topic><topic>Risk Factors</topic><topic>Tumor Microenvironment - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Chi</creatorcontrib><creatorcontrib>Zhang, Qianfei</creatorcontrib><creatorcontrib>Greten, Tim F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The FEBS journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Chi</au><au>Zhang, Qianfei</au><au>Greten, Tim F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes</atitle><jtitle>The FEBS journal</jtitle><addtitle>FEBS J</addtitle><date>2018-02</date><risdate>2018</risdate><volume>285</volume><issue>4</issue><spage>752</spage><epage>762</epage><pages>752-762</pages><issn>1742-464X</issn><eissn>1742-4658</eissn><abstract>Hepatocellular carcinoma (HCC) is the sixth most frequent neoplasm and the second leading cause of cancer‐related deaths worldwide. Nonalcoholic fatty liver disease (NAFLD), a common disorder in obese people, has been identified as an important risk factor for HCC. Following the increasing prevalence of obesity, it is expected that the contribution of NAFLD to HCC's incidence worldwide will grow. Recently, a number of studies have been published, which help us better understand cellular and molecular mechanisms of how NAFLD promotes hepatocarcinogensis. Inflammatory cytokines, ER stress and circadian dysregulation, which mediate hepatocyte injury and NAFLD progression, have been identified to promote malignant transformation of hepatocytes. Besides these ‘intrinsic’ effects, lipid dysregulation dramatically affects the liver local microenvironment. The reshaped immune environment has also been found to contribute to the NAFLD‐mediated hepatocarcinogenesis. This review explores recent findings of both ‘intrinsic’ effects on hepatocytes and the role of the local environment in NAFLD‐promoted HCC development. Nonalcoholic fatty liver disease promotes HCC through both direct effects on hepatocytes, and indirect effects on the environment shaping this into a protumor milieu. NAFLD‐associated events such as the increase of inflammatory cytokines alter gene expression profile of hepatocytes and contribute to malignant transformation. NAFLD also changes the population and functions of liver nonparenchymal cells and favors tumor development.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>28857485</pmid><doi>10.1111/febs.14209</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1742-464X
ispartof The FEBS journal, 2018-02, Vol.285 (4), p.752-762
issn 1742-464X
1742-4658
language eng
recordid cdi_proquest_miscellaneous_1934280411
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; Free Full-Text Journals in Chemistry
subjects Animals
Carcinoma, Hepatocellular - immunology
Carcinoma, Hepatocellular - metabolism
Carcinoma, Hepatocellular - pathology
CD4 T cells
CD8 T cells
circadian dysregulation
Circadian rhythms
Cytokines
ER stress
Fatty liver
gut microbiome
HCC
Hepatocellular carcinoma
Hepatocytes
Hepatocytes - immunology
Hepatocytes - metabolism
Hepatocytes - pathology
Humans
Inflammation
inflammatory cytokine
Liver
Liver cancer
Liver diseases
Liver Neoplasms - immunology
Liver Neoplasms - metabolism
Liver Neoplasms - pathology
Molecular modelling
myeloid cells
NAFLD
NKT cells
Non-alcoholic Fatty Liver Disease - immunology
Non-alcoholic Fatty Liver Disease - metabolism
Non-alcoholic Fatty Liver Disease - pathology
Obesity
Risk Factors
Tumor Microenvironment - immunology
title Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T21%3A19%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nonalcoholic%20fatty%20liver%20disease%20promotes%20hepatocellular%20carcinoma%20through%20direct%20and%20indirect%20effects%20on%20hepatocytes&rft.jtitle=The%20FEBS%20journal&rft.au=Ma,%20Chi&rft.date=2018-02&rft.volume=285&rft.issue=4&rft.spage=752&rft.epage=762&rft.pages=752-762&rft.issn=1742-464X&rft.eissn=1742-4658&rft_id=info:doi/10.1111/febs.14209&rft_dat=%3Cproquest_cross%3E2007922488%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2007922488&rft_id=info:pmid/28857485&rfr_iscdi=true